Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Fowler

Showing results (321-330 of 341) with videos related to

Pageof 35
Sort By:
BJU International|March 31, 2004
Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatmentC M Brady, A N Apostolidis, M Harper, et al.
European Urology|November 19, 2004
EAU guidelines on chronic pelvic painM Fall, A P Baranowski, C J Fowler, et al.
BJU International|February 7, 2004
Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxinA N Apostolidis, Y Yiangou, C M Brady, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonistL Rënyi, J L Evenden, C J Fowler, et al.
Bone Marrow Transplantation|February 3, 2009
Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experienceC J Fowler, A Dunn, B Hayes-Lattin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1992
Neurological and neuropsychological performance in HIV seropositive men without symptomsR H McAllister, M V Herns, M J Harrison, et al.
British Journal of Pharmacology|July 2, 2010
Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolaseL Thors, J J Burston, B J Alter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 3, 2005
Conservative bladder management in advanced multiple sclerosisD De Ridder, D Ost, F Van der Aa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 5, 1998
Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS studyM J Harrison, S P Newman, M A Hall-Craggs, et al.
Molecular Psychiatry|October 29, 2014
Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessmentL Cheng, J D Doecke, R A Sharples, et al.
Pageof 35

Showing results (321-330 of 341) with videos related to

Sort By:
Pageof 35
BJU International|March 31, 2004
Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatmentC M Brady, A N Apostolidis, M Harper, et al.
European Urology|November 19, 2004
EAU guidelines on chronic pelvic painM Fall, A P Baranowski, C J Fowler, et al.
BJU International|February 7, 2004
Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxinA N Apostolidis, Y Yiangou, C M Brady, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonistL Rënyi, J L Evenden, C J Fowler, et al.
Bone Marrow Transplantation|February 3, 2009
Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experienceC J Fowler, A Dunn, B Hayes-Lattin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1992
Neurological and neuropsychological performance in HIV seropositive men without symptomsR H McAllister, M V Herns, M J Harrison, et al.
British Journal of Pharmacology|July 2, 2010
Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolaseL Thors, J J Burston, B J Alter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 3, 2005
Conservative bladder management in advanced multiple sclerosisD De Ridder, D Ost, F Van der Aa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 5, 1998
Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS studyM J Harrison, S P Newman, M A Hall-Craggs, et al.
Molecular Psychiatry|October 29, 2014
Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessmentL Cheng, J D Doecke, R A Sharples, et al.
Pageof 35